[
  {
    "ts": null,
    "headline": "Medtronic Posts Better-Than-Expected Earnings. Here’s Why the Stock Is Falling.",
    "summary": "Medical device maker  Medtronic  reported quarterly earnings and net sales that topped consensus views.  Medtronic  on Tuesday posted fiscal third-quarter adjusted earnings of $1.36 a share, narrowly beating analysts’ forecasts of $1.34.  Medtronic’s profit declined from the same period last year on a non-adjusted basis, slipping to $1.14 billion from $1.29 billion.",
    "url": "https://finnhub.io/api/news?id=049986bb1794b0e6318935b32003f3cb30bcf9a167c7c7fd90bfea295927eeeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771333200,
      "headline": "Medtronic Posts Better-Than-Expected Earnings. Here’s Why the Stock Is Falling.",
      "id": 139122218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Medical device maker  Medtronic  reported quarterly earnings and net sales that topped consensus views.  Medtronic  on Tuesday posted fiscal third-quarter adjusted earnings of $1.36 a share, narrowly beating analysts’ forecasts of $1.34.  Medtronic’s profit declined from the same period last year on a non-adjusted basis, slipping to $1.14 billion from $1.29 billion.",
      "url": "https://finnhub.io/api/news?id=049986bb1794b0e6318935b32003f3cb30bcf9a167c7c7fd90bfea295927eeeb"
    }
  },
  {
    "ts": null,
    "headline": "Truist Securities Reiterates Buy on DexCom, Lowers Price Target to $80",
    "summary": "Truist Securities  analyst Richard Newitter   reiterates DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $82 to $80.",
    "url": "https://finnhub.io/api/news?id=97aacd1f06c6e6d5b2190fc7ec5c5362246f549d60e2b1d510d222368f346629",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771329142,
      "headline": "Truist Securities Reiterates Buy on DexCom, Lowers Price Target to $80",
      "id": 139134760,
      "image": "",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": "Truist Securities  analyst Richard Newitter   reiterates DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $82 to $80.",
      "url": "https://finnhub.io/api/news?id=97aacd1f06c6e6d5b2190fc7ec5c5362246f549d60e2b1d510d222368f346629"
    }
  }
]